Peregrine Pharmaceuticals to Report Third Quarter FY 2010 Financial Results

Peregrine Pharmaceuticals to Present at Two Upcoming Investor Conferences

New Scientific Publication Highlights Long-Term Survival of Brain Cancer Patients Treated With Peregrine Pharmaceuticals' Cotara(R)

Peregrine Pharmaceuticals to Present at the 12th Annual BIO CEO and Investor Conference

Peregrine Pharmaceuticals Appoints Dr. Marvin R. Garovoy as Head of Clinical Science

Peregrine Pharmaceuticals to Present at the OneMedForum 2010 Finance Conference

Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010

Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results

Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial

Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference